View Single Post
Old 10-17-2010, 03:04 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,149
NICE Publishes Appeal Decision On Lapatinib

The National Institute for Health and Clinical Excellence (NICE) has published the outcome of an appeal hearing relating to its draft guidance on the use of lapatinib (Tyverb, GlaxoSmithKline) for certain breast cancer patients...

More...
News is offline   Reply With Quote